Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	3.94B
Revenue (ttm)	1.61B
Net Income (ttm)	517.39M
Shares Out	22.75M
EPS (ttm)	n/a
PE Ratio	7.61
Forward PE	n/a
Dividend	13.19 (7.62%)
Ex-Dividend Date	Oct 27, 2025

Volume	390,967
Average Volume	340,122
Open	169.25
Previous Close	169.25
Day's Range	168.50 - 173.50
52-Week Range	47.15 - 232.95
Beta	0.06
RSI	45.17
Earnings Date	Nov 12, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2025, EGX:MPCI's revenue was 1.51 billion, an increase of 72.93% compared to the previous year's 871.91 million. Earnings were 505.28 million, an increase of 163.91%.